Synergistic Anticancer Effects of Silibinin and Sulforaphane: Targeting Gastric Cancer via PI3K/AKT and ERK1/2 MAPK Pathway Inhibition and Molecular Docking Insights

Documenti analoghi

• Puerarin Enhances the Sensitivity of Colorectal Cancer to 5‐Fluorouracil and Oxaliplatin by Inhibiting the PTEN/PI3K/AKT Signaling Pathway
  di: Xiaowei Wang, et al.
  Pubblicazione: (2025)
• Taichunamide‐A Inhibits Stomach Cancer Growth Through AKT/MAPK Pathway Suppression and EGFR Inhibitor Synergy
  di: Lian‐cheng Xu, et al.
  Pubblicazione: (2025)
• RETRACTION: Dieckol Inhibits Non‐Small–Cell Lung Cancer Cell Proliferation and Migration by Regulating the PI3K/AKT Signaling Pathway
  Pubblicazione: (2026)
• l‐Securinine Induces ROS‐Dependent Apoptosis on Pancreatic Cancer Cells via the PI3K/AKT/mTOR Signaling Pathway
  di: Ioanna A. Anastasiou, et al.
  Pubblicazione: (2024)
• SRSF3 Inhibits High Glucose and Palmitic Acid‐Induced Cardiomyocyte Apoptosis Through the PI3K/AKT and NF‐κB Pathways
  di: Peng Gao, et al.
  Pubblicazione: (2025)